Cart
sales@molnova.com
Tefludazine
CAS No. 80680-06-4
Tefludazine( —— )
Catalog No. M36001 CAS No. 80680-06-4
Tefludazine, a novel neuroleptic with a benzindone structure, is a compound with good oral activity and antagonistic effects on dopamine and 5-hydroxytryptamine receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 561 | In Stock |
|
| 10MG | 801 | In Stock |
|
| 25MG | 1216 | In Stock |
|
| 50MG | 1609 | In Stock |
|
| 100MG | 2167 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 4343 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTefludazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTefludazine, a novel neuroleptic with a benzindone structure, is a compound with good oral activity and antagonistic effects on dopamine and 5-hydroxytryptamine receptors.
-
DescriptionTefludazine, a novel neuroleptic with a benzindone structure, is a compound with good oral activity and antagonistic effects on dopamine and 5-hydroxytryptamine receptors. Tefludazine has shown potent dopamine (DA) antagonistic activity in in vitro and in vivo test models in mice, rats and dogs. Tefludazine is a therapeutic agent used to treat psychiatric disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80680-06-4
-
Formula Weight408.43
-
Molecular FormulaC22H24F4N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC(F)(C1=CC=C([C@H](C2=CC=C(C=C2)F)C[C@H]3N4CCN(CC4)CCO)C3=C1)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
1M6
1M6 (1-Methyl-6-nitroisatoic anhydride) is a SHAPE reagent for the detection of RNA chemical structures.
-
N'-Methylnicotinamid...
N-methylnicotinamide is a metabolite of niacin (or nicotinamide) and is commonly found in human urine. However low levels of urinary excretion of N-methylnicotinamide indicates niacin deficiency. In patients with liver cirrhosis nicotinamide methylation is increased leading to a rise in urinary N-methylnicotinamide. N-methylnicotinamide has been found to be a microbial metabolite.
-
TBOPP
TBOPP is a selective DOCK1 inhibitor (IC50 : 8.4 μM), with anti-tumor activity for broader types of tumors.
